These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 18971549

  • 1. Low-dose losartan therapy reduces proteinuria in normotensive patients with immunoglobulin A nephropathy.
    Shimizu A, Takei T, Uchida K, Tsuchiya K, Nitta K.
    Hypertens Res; 2008 Sep; 31(9):1711-7. PubMed ID: 18971549
    [Abstract] [Full Text] [Related]

  • 2. Low-dose combination therapy with temocapril and losartan reduces proteinuria in normotensive patients with immunoglobulin a nephropathy.
    Horita Y, Tadokoro M, Taura K, Suyama N, Taguchi T, Miyazaki M, Kohno S.
    Hypertens Res; 2004 Dec; 27(12):963-70. PubMed ID: 15894837
    [Abstract] [Full Text] [Related]

  • 3. Aldosterone breakthrough during therapy with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in proteinuric patients with immunoglobulin A nephropathy.
    Horita Y, Taura K, Taguchi T, Furusu A, Kohno S.
    Nephrology (Carlton); 2006 Oct; 11(5):462-6. PubMed ID: 17014562
    [Abstract] [Full Text] [Related]

  • 4. Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy.
    Russo D, Pisani A, Balletta MM, De Nicola L, Savino FA, Andreucci M, Minutolo R.
    Am J Kidney Dis; 1999 May; 33(5):851-6. PubMed ID: 10213639
    [Abstract] [Full Text] [Related]

  • 5. Effect of low-dose valsartan on proteinuria in normotensive immunoglobulin A nephropathy with minimal proteinuria: a randomized trial.
    Jo YI, Na HY, Moon JY, Han SW, Yang DH, Lee SH, Park HC, Choi HY, Lim SD, Kie JH, Lee YK, Shin SK.
    Korean J Intern Med; 2016 Mar; 31(2):335-43. PubMed ID: 26874511
    [Abstract] [Full Text] [Related]

  • 6. Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy.
    Russo D, Minutolo R, Pisani A, Esposito R, Signoriello G, Andreucci M, Balletta MM.
    Am J Kidney Dis; 2001 Jul; 38(1):18-25. PubMed ID: 11431176
    [Abstract] [Full Text] [Related]

  • 7. The effects of dual blockade of the renin-angiotensin system on urinary protein and transforming growth factor-beta excretion in 2 groups of patients with IgA and diabetic nephropathy.
    Song JH, Lee SW, Suh JH, Kim ES, Hong SB, Kim KA, Kim MJ.
    Clin Nephrol; 2003 Nov; 60(5):318-26. PubMed ID: 14640237
    [Abstract] [Full Text] [Related]

  • 8. Treatment with low-dose angiotensin-converting enzyme inhibitor (ACEI) plus angiotensin II receptor blocker (ARB) in pediatric patients with IgA nephropathy.
    Yang Y, Ohta K, Shimizu M, Nakai A, Kasahara Y, Yachie A, Koizumi S.
    Clin Nephrol; 2005 Jul; 64(1):35-40. PubMed ID: 16047643
    [Abstract] [Full Text] [Related]

  • 9. Lisinopril versus lisinopril and losartan for mild childhood IgA nephropathy: a randomized controlled trial (JSKDC01 study).
    Shima Y, Nakanishi K, Sako M, Saito-Oba M, Hamasaki Y, Hataya H, Honda M, Kamei K, Ishikura K, Ito S, Kaito H, Tanaka R, Nozu K, Nakamura H, Ohashi Y, Iijima K, Yoshikawa N, Japanese Study Group of Kidney Disease in Children (JSKDC).
    Pediatr Nephrol; 2019 May; 34(5):837-846. PubMed ID: 30284023
    [Abstract] [Full Text] [Related]

  • 10. Antiproteinuric effect of losartan in non-diabetic renal disease is not dependent on ACE insertion/deletion polymorphism.
    Park HC, Choi HY, Kim BS, Kang SW, Choi KH, Ha SK, Lee HY, Han DS.
    Kidney Blood Press Res; 2006 May; 29(4):216-24. PubMed ID: 16960460
    [Abstract] [Full Text] [Related]

  • 11. Effect of losartan and amlodipine on proteinuria and transforming growth factor-beta1 in patients with IgA nephropathy.
    Park HC, Xu ZG, Choi S, Goo YS, Kang SW, Choi KH, Ha SK, Lee HY, Han DS.
    Nephrol Dial Transplant; 2003 Jun; 18(6):1115-21. PubMed ID: 12748343
    [Abstract] [Full Text] [Related]

  • 12. Antiproteinuric effect of olmesartan in patients with IgA nephropathy.
    Tomino Y, Kawamura T, Kimura K, Endoh M, Hosoya T, Horikoshi S, Utsunomiya Y, Yasuda T, Toyoda M, Tsuge T, Kaneko K.
    J Nephrol; 2009 Jun; 22(2):224-31. PubMed ID: 19384840
    [Abstract] [Full Text] [Related]

  • 13. Hydroxychloroquine alleviates persistent proteinuria in IgA nephropathy.
    Gao R, Wu W, Wen Y, Li X.
    Int Urol Nephrol; 2017 Jul; 49(7):1233-1241. PubMed ID: 28349446
    [Abstract] [Full Text] [Related]

  • 14. Long-term antiproteinuric and renoprotective efficacy and safety of losartan in children with proteinuria.
    Ellis D, Vats A, Moritz ML, Reitz S, Grosso MJ, Janosky JE.
    J Pediatr; 2003 Jul; 143(1):89-97. PubMed ID: 12915830
    [Abstract] [Full Text] [Related]

  • 15. Add-on angiotensin receptor blockade with maximized ACE inhibition.
    Agarwal R.
    Kidney Int; 2001 Jun; 59(6):2282-9. PubMed ID: 11380832
    [Abstract] [Full Text] [Related]

  • 16. Dual renin-angiotensin system blockade plus oral methylprednisone for the treatment of proteinuria in IgA nephropathy.
    Trimarchi H, Muryan A, Young P, Forrester M, Iotti A, Pereyra H, Lombi F, Seminario O, Alonso M, Iotti R.
    Medicina (B Aires); 2007 Jun; 67(5):445-50. PubMed ID: 18051227
    [Abstract] [Full Text] [Related]

  • 17. Thiazide diuretics enhance nocturnal blood pressure fall and reduce proteinuria in immunoglobulin A nephropathy treated with angiotensin II modulators.
    Uzu T, Harada T, Namba T, Yamamoto R, Takahara K, Yamauchi A, Kimura G.
    J Hypertens; 2005 Apr; 23(4):861-5. PubMed ID: 15775792
    [Abstract] [Full Text] [Related]

  • 18. Randomized, controlled study of the effects of losartan versus enalapril in small doses on proteinuria and tubular injury in primary glomerulonephritis.
    Tylicki L, Renke M, Rutkowski P, Rutkowski B, Lysiak-Szydłowska W.
    Med Sci Monit; 2005 Apr; 11(4):PI31-7. PubMed ID: 15795705
    [Abstract] [Full Text] [Related]

  • 19. Prednisolone co-administered with losartan confers renoprotection in patients with IgA nephropathy.
    Horita Y, Tadokoro M, Taura K, Ashida R, Hiu M, Taguchi T, Furusu A, Kohno S.
    Ren Fail; 2007 Apr; 29(4):441-6. PubMed ID: 17497466
    [Abstract] [Full Text] [Related]

  • 20. Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation.
    Tylicki L, Rutkowski P, Renke M, Rutkowski B.
    Am J Nephrol; 2002 Apr; 22(4):356-62. PubMed ID: 12169868
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.